Abstract
Abstract
Background
Systemic and local recurrences of urothelial bladder cancer (UBC) significantly impair survival after radical cystectomy (RC), but little is known about the impact of the recurrence of urothelial cancer in the upper urinary tract (UTUC). This report describes survival outcomes and their predictors for patients who underwent RC followed by radical nephroureterectomy (RNU) for UTUC.
Methods
The Surveillance, Epidemiology, and End Results database was queried to identify patients who underwent RC for UBC and subsequent RNU for UTUC. The Kaplan–Meier method and competing-risk Cox regression (CRR) were used for the survival analysis.
Results
Overall, 102 patients have undergone RNU within a median of 49 months (interquartile range [IQR], 27–76 months) since RC. Muscle-invasive UTUCs were predominant at RNU (n = 58; 56.7%), but organ-confined bladder tumors were most frequent at RC (n = 42, 41.5%). After RNU, the estimated 5-year overall survival (OS) was 25.9%, the cancer-specific survival (CSS) was 35.6%, the median OS was 23 months (IQR, 11–63 months), and the CSS was 34 months (IQR, 13–132 months). In the multivariable CRR, the factors predictive for CSS after RNU included male gender (hazard ratio [HR], 2.36; 95% confidence interval [CI], 1.03–5.42; p < 0.05), muscle-invasive UTUC (HR, 2.20; 95% CI, 1.13–4.28; p < 0.05), and the presence of distant metastasis (HR,11.59; 95% CI, 5.33–25.2; p < 0.001).
Conclusions
In conclusion, the patients who underwent RNU for UTUC after RC for UBC experienced poor OS and CSS. The majority of RNUs were performed for locally advanced tumors. The independent risk factors for worse OS and CSS after RNU were UTUC T stage, presence of metastasis, and male gender.
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. van Doeveren T, van de Werken HJG, van Riet J, Aben KKH, van Leeuwen PJ, Zwarthoff EC, et al. Synchronous and metachronous urothelial carcinoma of the upper urinary tract and the bladder: are they clonally related? A systematic review. Urol Oncol Semin Orig Investig. 2020;38:590–8.
2. Professionals SO. Uroweb [cited 16 June 2021]. EAU guidelines: muscle-invasive and metastatic bladder cancer. Retrieved at https://uroweb.org/guideline/bladder-cancer-muscle-invasive-and-metastatic/
3. Ślusarczyk A, Zapała P, Zapała Ł, Piecha T, Radziszewski P. Prediction of BCG responses in non-muscle-invasive bladder cancer in the era of novel immunotherapeutics. Int Urol Nephrol. 2019;51:1089–99.
4. Gakis G, Black PC, Bochner BH, Boorjian SA, Stenzl A, Thalmann GN, et al. Systematic review on the fate of the remnant urothelium after radical cystectomy. Eur Urol. 2017;71:545–57.
5. Sanderson KM, Rouprêt M. Upper urinary tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: an update on the risk factors, surveillance regimens and treatments. BJU Int. 2007;100:11–6.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献